Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hepatitis B 3Carcinoma, Hepatocellular 3Lymphoma, B-Cell 1Lymphoma 1Hepatitis B, Chronic 1

Interventions

Rituximab 14pirtobrutinib 6ibrutinib 4Vincristine 4Doxorubicin 4Prednisone 3Cytarabine 3Cyclophosphamide 3zanubrutinib 2acalabrutinib 2Methotrexate 2Etoposide 2Bendamustine Hydrochloride 2venetoclax 1tositumomab I-131 1idelalisib 1ibritumomab tiuxetan 1etoposide phosphate 1entecavir 1cirmtuzumab 1axicabtagene ciloleucel 1VAP-cyclo protocol 1Tenofovir 1Radiotherapy 1Melphalan 1Ifosfamide 1Gemcitabine 1Everolimus 1Drug Therapy 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, B-Cell × Tenofovir × Clear all
NCT04539119 2020-09-04

Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

Ruijin Hospital

Phase 3 Unknown
120 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡